Loading…

Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment

Ocular allergy refers to a variety of hypersensitivity disorders that affect the lid, conjunctiva, and/or cornea. Its incidence is estimated at over 20% of the general population in the United States. This review will discuss the various forms of ocular allergy, their pathophysiology, clinical prese...

Full description

Saved in:
Bibliographic Details
Published in:The ocular surface 2003-07, Vol.1 (3), p.127-149
Main Authors: Abelson, Mark B., Smith, Lisa, Chapin, Matthew
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283
cites cdi_FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283
container_end_page 149
container_issue 3
container_start_page 127
container_title The ocular surface
container_volume 1
creator Abelson, Mark B.
Smith, Lisa
Chapin, Matthew
description Ocular allergy refers to a variety of hypersensitivity disorders that affect the lid, conjunctiva, and/or cornea. Its incidence is estimated at over 20% of the general population in the United States. This review will discuss the various forms of ocular allergy, their pathophysiology, clinical presentation, and treatment. New frontiers in mechanisms, therapy, and management in the office are emphasized throughout.
doi_str_mv 10.1016/S1542-0124(12)70140-4
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71608446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1542012412701404</els_id><sourcerecordid>71608446</sourcerecordid><originalsourceid>FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMofv8EpSdRcHUmzceuFyl-Q8WDeg7Z7EQju21NdoX-e7e24tHTDMPzzjAPYwcIZwiozp9RCp4BcnGM_EQDCsjEGtvGYqgzWeBwve9_kS22k9IHwFAp4JtsCzVoqYTYZqMn19U2DkZ1TfEtuMF1SGQTXQweyb3bSUhNOv0dDp67MmvnM-pHL5Fs29Ck3WMb3taJ9ld1l73e3rxc3Wfjp7uHq9E4c1yrNlMiz72QnHsoKuWl1EDWg-eyKIUsCxRaWo0AOWLFuapKTblE8Mp6Lng-3GVHy72zOP3sKLWmCclRXdsJTbtkNCrIhVA9KJegi9OUInkzi6GxcW4QzMKd-XFnFmIMcvPjzog-d7g60JUNVX-plaweuFwC1L_5FSia5AJNHFUhkmtNNQ3_nPgGSY17nA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71608446</pqid></control><display><type>article</type><title>Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment</title><source>Elsevier</source><creator>Abelson, Mark B. ; Smith, Lisa ; Chapin, Matthew</creator><creatorcontrib>Abelson, Mark B. ; Smith, Lisa ; Chapin, Matthew</creatorcontrib><description>Ocular allergy refers to a variety of hypersensitivity disorders that affect the lid, conjunctiva, and/or cornea. Its incidence is estimated at over 20% of the general population in the United States. This review will discuss the various forms of ocular allergy, their pathophysiology, clinical presentation, and treatment. New frontiers in mechanisms, therapy, and management in the office are emphasized throughout.</description><identifier>ISSN: 1542-0124</identifier><identifier>EISSN: 1937-5913</identifier><identifier>DOI: 10.1016/S1542-0124(12)70140-4</identifier><identifier>PMID: 17075644</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>allergic conjunctivitis ; allergic mediators ; antihistamines ; histamine ; lid swelling ; mast cell stabilizers ; mast cells ; ocular allergy ; ocular inflammation ; rhinoconjunctivitis ; steroids</subject><ispartof>The ocular surface, 2003-07, Vol.1 (3), p.127-149</ispartof><rights>2003 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283</citedby><cites>FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17075644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abelson, Mark B.</creatorcontrib><creatorcontrib>Smith, Lisa</creatorcontrib><creatorcontrib>Chapin, Matthew</creatorcontrib><title>Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment</title><title>The ocular surface</title><addtitle>Ocul Surf</addtitle><description>Ocular allergy refers to a variety of hypersensitivity disorders that affect the lid, conjunctiva, and/or cornea. Its incidence is estimated at over 20% of the general population in the United States. This review will discuss the various forms of ocular allergy, their pathophysiology, clinical presentation, and treatment. New frontiers in mechanisms, therapy, and management in the office are emphasized throughout.</description><subject>allergic conjunctivitis</subject><subject>allergic mediators</subject><subject>antihistamines</subject><subject>histamine</subject><subject>lid swelling</subject><subject>mast cell stabilizers</subject><subject>mast cells</subject><subject>ocular allergy</subject><subject>ocular inflammation</subject><subject>rhinoconjunctivitis</subject><subject>steroids</subject><issn>1542-0124</issn><issn>1937-5913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LAzEQhoMofv8EpSdRcHUmzceuFyl-Q8WDeg7Z7EQju21NdoX-e7e24tHTDMPzzjAPYwcIZwiozp9RCp4BcnGM_EQDCsjEGtvGYqgzWeBwve9_kS22k9IHwFAp4JtsCzVoqYTYZqMn19U2DkZ1TfEtuMF1SGQTXQweyb3bSUhNOv0dDp67MmvnM-pHL5Fs29Ck3WMb3taJ9ld1l73e3rxc3Wfjp7uHq9E4c1yrNlMiz72QnHsoKuWl1EDWg-eyKIUsCxRaWo0AOWLFuapKTblE8Mp6Lng-3GVHy72zOP3sKLWmCclRXdsJTbtkNCrIhVA9KJegi9OUInkzi6GxcW4QzMKd-XFnFmIMcvPjzog-d7g60JUNVX-plaweuFwC1L_5FSia5AJNHFUhkmtNNQ3_nPgGSY17nA</recordid><startdate>200307</startdate><enddate>200307</enddate><creator>Abelson, Mark B.</creator><creator>Smith, Lisa</creator><creator>Chapin, Matthew</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200307</creationdate><title>Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment</title><author>Abelson, Mark B. ; Smith, Lisa ; Chapin, Matthew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>allergic conjunctivitis</topic><topic>allergic mediators</topic><topic>antihistamines</topic><topic>histamine</topic><topic>lid swelling</topic><topic>mast cell stabilizers</topic><topic>mast cells</topic><topic>ocular allergy</topic><topic>ocular inflammation</topic><topic>rhinoconjunctivitis</topic><topic>steroids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abelson, Mark B.</creatorcontrib><creatorcontrib>Smith, Lisa</creatorcontrib><creatorcontrib>Chapin, Matthew</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The ocular surface</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abelson, Mark B.</au><au>Smith, Lisa</au><au>Chapin, Matthew</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment</atitle><jtitle>The ocular surface</jtitle><addtitle>Ocul Surf</addtitle><date>2003-07</date><risdate>2003</risdate><volume>1</volume><issue>3</issue><spage>127</spage><epage>149</epage><pages>127-149</pages><issn>1542-0124</issn><eissn>1937-5913</eissn><abstract>Ocular allergy refers to a variety of hypersensitivity disorders that affect the lid, conjunctiva, and/or cornea. Its incidence is estimated at over 20% of the general population in the United States. This review will discuss the various forms of ocular allergy, their pathophysiology, clinical presentation, and treatment. New frontiers in mechanisms, therapy, and management in the office are emphasized throughout.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>17075644</pmid><doi>10.1016/S1542-0124(12)70140-4</doi><tpages>23</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1542-0124
ispartof The ocular surface, 2003-07, Vol.1 (3), p.127-149
issn 1542-0124
1937-5913
language eng
recordid cdi_proquest_miscellaneous_71608446
source Elsevier
subjects allergic conjunctivitis
allergic mediators
antihistamines
histamine
lid swelling
mast cell stabilizers
mast cells
ocular allergy
ocular inflammation
rhinoconjunctivitis
steroids
title Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A36%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ocular%20Allergic%20Disease:%20Mechanisms,%20Disease%20Sub-types,%20Treatment&rft.jtitle=The%20ocular%20surface&rft.au=Abelson,%20Mark%20B.&rft.date=2003-07&rft.volume=1&rft.issue=3&rft.spage=127&rft.epage=149&rft.pages=127-149&rft.issn=1542-0124&rft.eissn=1937-5913&rft_id=info:doi/10.1016/S1542-0124(12)70140-4&rft_dat=%3Cproquest_cross%3E71608446%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71608446&rft_id=info:pmid/17075644&rfr_iscdi=true